A $1,000-a-day hepatitis C pill is giving insurers fits. Doctors have openly complained about the high prices of certain cancer medicines. And even the cost of some generic drugs – which are supposed to help lower health care bills – are starting to rise.. Everywhere you look, it seems, paying for prescription drugs is a controversial – and urgent – topic.. So let’s chat about this. .  – and this session will be devoted to pharmaceutical pricing. And we will have a special guest – Dana Goldman, who is the director of the Schaeffer Center for Health Policy and Economics at the University of Southern California.